Your browser is no longer supported. Please, upgrade your browser.
Settings
QTRX Quanterix Corporation daily Stock Chart
QTRX [NASD]
Quanterix Corporation
Index- P/E- EPS (ttm)-1.63 Insider Own9.10% Shs Outstand28.18M Perf Week2.95%
Market Cap787.05M Forward P/E- EPS next Y-1.35 Insider Trans-7.45% Shs Float25.65M Perf Month-0.21%
Income-43.00M PEG- EPS next Q-0.49 Inst Own85.20% Short Float4.14% Perf Quarter39.12%
Sales60.10M P/S13.10 EPS this Y-13.40% Inst Trans-0.17% Short Ratio5.85 Perf Half Y20.59%
Book/sh4.22 P/B6.61 EPS next Y22.40% ROA-27.50% Target Price33.50 Perf Year-13.60%
Cash/sh- P/C- EPS next 5Y- ROE-37.50% 52W Range10.90 - 35.29 Perf YTD17.99%
Dividend- P/FCF- EPS past 5Y- ROI-30.40% 52W High-21.00% Beta-
Dividend %- Quick Ratio6.20 Sales past 5Y- Gross Margin46.00% 52W Low155.90% ATR1.44
Employees248 Current Ratio6.80 Sales Q/Q27.60% Oper. Margin-73.30% RSI (14)58.30 Volatility5.56% 5.26%
OptionableNo Debt/Eq0.00 EPS Q/Q1.80% Profit Margin-71.50% Rel Volume0.79 Prev Close27.80
ShortableYes LT Debt/Eq0.06 EarningsMay 05 AMC Payout- Avg Volume181.63K Price27.88
Recom- SMA205.30% SMA505.83% SMA20017.88% Volume144,307 Change0.29%
Jul-05-20 10:02PM  
Jun-26-20 09:37AM  
Jun-11-20 04:10PM  
May-29-20 12:37PM  
May-13-20 09:45AM  
May-11-20 09:14AM  
08:26AM  
May-06-20 10:02AM  
May-05-20 04:05PM  
May-01-20 11:00AM  
Apr-28-20 02:45PM  
Apr-24-20 06:04PM  
Apr-14-20 10:05AM  
Apr-10-20 04:00PM  
Apr-09-20 01:15PM  
Mar-27-20 09:45AM  
Mar-11-20 08:13AM  
Mar-09-20 04:05PM  
Feb-21-20 04:32PM  
Feb-11-20 11:44AM  
Jan-31-20 10:04AM  
Jan-10-20 02:03PM  
Dec-19-19 04:23PM  
Dec-11-19 10:27AM  
Nov-06-19 04:01PM  
Nov-04-19 04:00PM  
Nov-01-19 09:41AM  
Oct-25-19 09:13AM  
Oct-22-19 04:30PM  
Oct-18-19 11:13AM  
Oct-03-19 09:00AM  
Oct-01-19 09:46AM  
Sep-26-19 07:00AM  
Sep-24-19 01:14PM  
Sep-16-19 06:21PM  
Sep-11-19 08:00AM  
Aug-13-19 04:21PM  
Aug-09-19 07:45AM  
Aug-07-19 04:23PM  
08:25AM  
Aug-06-19 08:30AM  
Jul-31-19 09:00AM  
Jul-30-19 10:30AM  
Jul-26-19 11:16AM  
Jul-11-19 01:30PM  
Jun-28-19 12:15PM  
Jun-27-19 10:43AM  
Jun-26-19 04:00PM  
Jun-06-19 07:03AM  
Jun-04-19 04:00PM  
May-29-19 04:00PM  
May-16-19 10:30AM  
May-11-19 01:27PM  
May-10-19 11:23AM  
May-09-19 04:00PM  
May-06-19 11:30AM  
May-02-19 04:00PM  
Apr-01-19 07:14AM  
Mar-28-19 04:00PM  
Mar-18-19 05:48PM  
Mar-08-19 01:15AM  
Mar-07-19 04:00PM  
Feb-26-19 04:00PM  
Feb-21-19 02:45PM  
Feb-19-19 06:04AM  
Jan-14-19 11:45AM  
Jan-10-19 12:00PM  
Jan-04-19 04:17PM  
Dec-20-18 10:11AM  
Dec-13-18 03:08PM  
Nov-26-18 01:00PM  
Nov-21-18 08:15AM  
Nov-13-18 04:00PM  
Nov-07-18 09:00AM  
Nov-01-18 04:00PM  
Oct-25-18 04:05PM  
Oct-22-18 04:30PM  
Oct-09-18 12:00AM  
Sep-26-18 09:00AM  
Sep-18-18 10:45AM  
Sep-12-18 05:15PM  
Sep-05-18 09:00AM  
Aug-08-18 04:00PM  
Aug-06-18 09:32AM  
Jul-30-18 09:00AM  
Jul-26-18 09:00AM  
Jul-23-18 01:00PM  
Jun-13-18 09:30AM  
May-09-18 04:00PM  
May-02-18 09:00AM  
Apr-27-18 09:00AM  
Mar-21-18 11:00AM  
Mar-20-18 09:00AM  
Mar-14-18 04:05PM  
Mar-08-18 08:00AM  
Mar-07-18 12:56PM  
Feb-08-18 10:00AM  
Jan-22-18 04:52PM  
Jan-04-18 09:03AM  
Jan-02-18 11:35AM  
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Madaus Martin DDirectorJun 25Option Exercise1.931,6003,08812,145Jun 26 04:01 PM
Madaus Martin DDirectorJun 25Sale26.081,60041,72810,545Jun 26 04:01 PM
Madaus Martin DDirectorJun 24Option Exercise1.931,6003,08812,145Jun 26 04:01 PM
Madaus Martin DDirectorJun 24Sale26.391,60042,22410,545Jun 26 04:01 PM
HRUSOVSKY E KEVINChairman, President & CEOJun 23Sale27.075,000135,3451,074,637Jun 25 04:01 PM
HRUSOVSKY E KEVINChairman, President & CEOJun 18Sale26.885,500147,8261,079,637Jun 22 04:04 PM
Duffy David C.SVP R&D and CTOJun 16Sale26.351,66743,92549,525Jun 18 04:58 PM
Roskey Mark T.SVP, Commercial & AcceleratorJun 15Option Exercise2.965,00014,80026,648Jun 15 07:04 PM
Roskey Mark T.SVP, Commercial & AcceleratorJun 15Sale24.805,000124,02521,648Jun 15 07:04 PM
Fry John JGeneral Counsel & SecretaryJun 11Sale24.771,84245,61831,803Jun 12 04:36 PM
Madaus Martin DDirectorJun 09Option Exercise1.931,6003,08812,145Jun 10 04:09 PM
Madaus Martin DDirectorJun 09Sale25.371,60040,59210,545Jun 10 04:09 PM
Madaus Martin DDirectorJun 08Option Exercise1.931,6003,08812,145Jun 10 04:09 PM
Madaus Martin DDirectorJun 08Sale25.901,60041,44010,545Jun 10 04:09 PM
HRUSOVSKY E KEVINChairman, President & CEOJun 03Sale27.495,000137,4721,085,137Jun 03 06:59 PM
Chaubal AmolChief Financial OfficerJun 01Sale27.321183,22425,844Jun 03 07:01 PM
HRUSOVSKY E KEVINChairman, President & CEOJun 01Sale27.323,33190,9981,090,137Jun 03 06:59 PM
Mattoon DawnSr. VP, Research ProductsJun 01Sale27.321624,42632,142Jun 03 06:50 PM
Roskey Mark T.SVP, Commercial & AcceleratorJun 01Sale27.32932,54121,648Jun 03 06:46 PM
Madaus Martin DDirectorMay 28Option Exercise1.931,6003,08812,145May 29 05:13 PM
Madaus Martin DDirectorMay 28Sale26.511,60042,41610,545May 29 05:13 PM
Madaus Martin DDirectorMay 27Option Exercise1.931,6003,08812,145May 29 05:13 PM
Madaus Martin DDirectorMay 27Sale26.021,60041,63210,545May 29 05:13 PM
HRUSOVSKY E KEVINChairman, President & CEOMay 26Sale25.645,000128,2241,093,468May 28 04:35 PM
Roskey Mark T.SVP, Commercial & AcceleratorMay 18Option Exercise2.965,00014,80026,741May 20 05:55 PM
Roskey Mark T.SVP, Commercial & AcceleratorMay 18Sale25.605,000128,01221,741May 20 05:55 PM
Madaus Martin DDirectorMay 13Option Exercise1.931,6003,08812,145May 14 05:45 PM
Madaus Martin DDirectorMay 13Sale26.601,60042,56010,545May 14 05:45 PM
Madaus Martin DDirectorMay 12Option Exercise1.931,6003,08812,145May 14 05:45 PM
Madaus Martin DDirectorMay 12Sale27.861,60044,57610,545May 14 05:45 PM
HRUSOVSKY E KEVINChairman, President & CEOMay 11Sale27.475,000137,3721,098,468May 12 07:16 PM
Duffy David C.SVP R&D and CTOMay 08Sale26.521,66744,20951,192May 12 06:21 PM
HRUSOVSKY E KEVINChairman, President & CEOMay 06Sale27.095,000135,4571,103,468May 08 04:35 PM
HRUSOVSKY E KEVINChairman, President & CEOMay 01Sale25.443,39986,4781,108,468May 04 05:22 PM
Mattoon DawnSr. VP, Research ProductsMay 01Sale25.441654,19832,304May 04 05:20 PM
Roskey Mark T.SVP, Commercial & AcceleratorMay 01Sale25.44952,41721,741May 04 05:18 PM
Chaubal AmolChief Financial OfficerMay 01Sale25.441203,05325,962Jun 03 07:01 PM
Madaus Martin DDirectorApr 28Option Exercise1.933,2006,17613,745Apr 29 04:37 PM
Madaus Martin DDirectorApr 28Sale26.052,50065,136164,966Apr 29 04:37 PM
Madaus Martin DDirectorApr 28Sale26.263,20084,02710,545Apr 29 04:37 PM
Madaus Martin DDirectorApr 27Sale26.712,30061,439167,466Apr 29 04:37 PM
HRUSOVSKY E KEVINChairman, President & CEOApr 23Sale24.925,000124,5871,111,867Apr 23 09:45 PM
HRUSOVSKY E KEVINChairman, President & CEOApr 21Sale23.675,000118,3511,116,867Apr 23 09:45 PM
Madaus Martin DDirectorApr 15Option Exercise1.931,6003,08812,145Apr 16 04:08 PM
Duffy David C.SVP R&D and CTOApr 15Sale20.871,66734,79052,859Apr 17 04:08 PM
Madaus Martin DDirectorApr 15Sale20.902,30048,060169,766Apr 16 04:08 PM
Madaus Martin DDirectorApr 15Sale20.871,60033,39210,545Apr 16 04:08 PM
Madaus Martin DDirectorApr 14Option Exercise1.931,6003,08812,145Apr 16 04:08 PM
Madaus Martin DDirectorApr 14Sale21.852,30050,252172,066Apr 16 04:08 PM
Madaus Martin DDirectorApr 14Sale20.391,60032,62410,545Apr 16 04:08 PM
Chaubal AmolChief Financial OfficerApr 14Sale20.341,46329,75326,082Jun 03 07:01 PM
Roskey Mark T.SVP, Commercial & AcceleratorApr 13Option Exercise2.965,00014,80026,836Apr 14 06:48 PM
Roskey Mark T.SVP, Commercial & AcceleratorApr 13Sale21.005,000105,01321,836Apr 14 06:48 PM
HRUSOVSKY E KEVINChairman, President & CEOApr 09Sale22.075,000110,3551,121,867Apr 09 06:11 PM
HRUSOVSKY E KEVINChairman, President & CEOApr 07Sale20.845,000104,1971,126,867Apr 09 06:11 PM
Madaus Martin DDirectorApr 06Sale20.354,40089,526174,366Apr 08 04:06 PM
Madaus Martin DDirectorApr 03Option Exercise1.931,6003,08812,145Apr 03 05:53 PM
HRUSOVSKY E KEVINChairman, President & CEOApr 03Sale20.00621,2401,131,867Apr 03 04:28 PM
Madaus Martin DDirectorApr 03Sale20.001,60032,00010,545Apr 03 05:53 PM
Madaus Martin DDirectorApr 03Sale20.563,30067,861178,766Apr 03 05:53 PM
Madaus Martin DDirectorApr 02Option Exercise1.934,8009,26415,345Apr 03 05:53 PM
Madaus Martin DDirectorApr 02Sale20.011,50030,022182,066Apr 03 05:53 PM
Madaus Martin DDirectorApr 02Sale20.004,80096,00010,545Apr 03 05:53 PM
HRUSOVSKY E KEVINChairman, President & CEOApr 02Sale20.025,438108,8691,131,929Apr 03 04:28 PM
HRUSOVSKY E KEVINChairman, President & CEOApr 01Sale17.443,23356,3991,137,367Apr 02 05:00 PM
Mattoon DawnSr. VP, Research ProductsApr 01Sale17.44971,69232,469Apr 02 04:54 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 31Sale17.44931,62221,836Apr 01 07:52 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 30Option Exercise2.965,00014,80026,929Apr 01 07:52 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 30Sale18.005,00090,00021,929Apr 01 07:52 PM
Duffy David C.SVP R&D and CTOMar 19Sale11.461,66719,10454,526Mar 20 05:03 PM
WALT DAVID RDirectorMar 13Buy16.6654,064900,9121,276,374Mar 17 04:12 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 13Sale16.045669,08121,929Mar 17 04:12 PM
Mattoon DawnSr. VP, Research ProductsMar 13Sale16.045669,08132,566Mar 17 04:12 PM
HRUSOVSKY E KEVINChairman, President & CEOMar 10Sale20.535,500112,9151,140,600Mar 12 04:12 PM
Madaus Martin DDirectorMar 05Option Exercise1.931,6003,08811,202Mar 06 05:46 PM
Madaus Martin DDirectorMar 05Sale22.991,60036,7849,602Mar 06 05:46 PM
Madaus Martin DDirectorMar 05Sale22.052,30050,724183,566Mar 06 05:46 PM
Madaus Martin DDirectorMar 04Option Exercise1.931,6003,08811,202Mar 06 05:46 PM
Madaus Martin DDirectorMar 04Sale23.471,60037,5529,602Mar 06 05:46 PM
Madaus Martin DDirectorMar 04Sale23.592,30054,247185,866Mar 06 05:46 PM
Mattoon DawnSr. VP, Research ProductsMar 02Sale22.931152,63633,132Mar 04 04:49 PM
Roskey Mark T.SVP, Commercial & AcceleratorMar 02Sale22.93461,05522,495Mar 04 04:49 PM
HRUSOVSKY E KEVINChairman, President & CEOMar 02Sale22.668,830200,0801,146,100Mar 04 08:50 PM
Madaus Martin DDirectorFeb 21Option Exercise1.931,6003,08811,202Feb 21 07:14 PM
Madaus Martin DDirectorFeb 21Sale27.982,30064,359188,166Feb 21 07:14 PM
Madaus Martin DDirectorFeb 21Sale28.261,60045,2169,602Feb 21 07:14 PM
Madaus Martin DDirectorFeb 20Option Exercise1.931,6003,08811,202Feb 21 07:14 PM
Madaus Martin DDirectorFeb 20Sale28.132,30064,705190,466Feb 21 07:14 PM
Madaus Martin DDirectorFeb 20Sale28.291,60045,2669,602Feb 21 07:14 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 18Option Exercise2.965,00014,80019,184Feb 20 08:18 PM
Roskey Mark T.SVP, Commercial & AcceleratorFeb 18Sale27.845,000139,19414,184Feb 20 08:18 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 12Sale27.176,500176,6141,115,933Feb 14 07:58 PM
Duffy David C.SVP R&D and CTOFeb 11Sale27.881,66746,47649,693Feb 11 04:50 PM
HRUSOVSKY E KEVINChairman, President & CEOFeb 06Sale27.566,500179,1401,122,433Feb 07 04:15 PM
Madaus Martin DDirectorFeb 05Option Exercise1.931,6003,08811,202Feb 06 04:44 PM
Madaus Martin DDirectorFeb 05Sale27.701,60044,3209,602Feb 06 04:44 PM
Madaus Martin DDirectorFeb 05Sale27.652,30063,594192,766Feb 06 04:44 PM
Madaus Martin DDirectorFeb 04Option Exercise1.931,6003,08811,202Feb 06 04:44 PM
Madaus Martin DDirectorFeb 04Sale26.521,60042,4329,602Feb 06 04:44 PM
Madaus Martin DDirectorFeb 04Sale26.952,30061,988195,066Feb 06 04:44 PM